IDENTIFYING BIOMARKERS OF DISEASE PROGRESSION IN PEDIATRIC AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE PATIENTS

被引：0
|
作者：
Baliga, M. [1 ]
Karimpour-fard, A. [2 ]
Klawitter, J. [2 ]
Christians, U. [2 ]
Cadnapaphornchai, M. [2 ,3 ]
Klawitter, J. [2 ]
机构：
[1] Univ Colorado, Sch Med, Aurora, CO USA
[2] Univ Colorado, Anschutz Med Campus, Aurora, CO USA
[3] Childrens Hosp Colorado, Aurora, CO USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2017年 / 65卷 / 01期
关键词：
D O I：
10.1136/jim-2016-000365.230
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
230
引用
收藏
页码：195 / 195
页数：1
相关论文
共 50 条
  • [31] Fibrosis and progression of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
    Norman, Jill
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (10): : 1327 - 1336
  • [32] How to identify the rapid progression patients in the autosomal dominant polycystic kidney disease?
    Le Meur, Y.
    Fartoux, L.
    NEPHROLOGIE & THERAPEUTIQUE, 2016, 12 : S13 - S15
  • [33] The impact of asymptomatic kidney stones on disease progression in autosomal dominant polycystic kidney disease
    Elcioglu, Omer Celal
    Yatci, Beyza
    Ozturk, Burak Baris
    Mirioglu, Safak
    Gursu, Meltem
    Kazancioglu, Rumeyza
    BMC NEPHROLOGY, 2025, 26 (01)
  • [34] SOMATOSTATIN IS NOT ASSOCIATED WITH DISEASE SEVERITY OR RATE OF DISEASE PROGRESSION IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Messchendorp, A. Lianne
    Spithoven, Edwin M.
    Meijer, Esther
    Bakker, Stephan J.
    Boertien, Wendy E.
    Casteleijn, Niek F.
    Dam, Wendy
    van den Born, Jaap
    Tonnis, Wouter F.
    Gaillard, Carlo A. J. M.
    Gansevoort, Ron T.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 362 - 363
  • [35] DECADE IN REVIEW-POLYCYSTIC KIDNEY DISEASE Slowing progression of autosomal dominant polycystic kidney disease
    Schrier, Robert W.
    NATURE REVIEWS NEPHROLOGY, 2015, 11 (11) : 638 - +
  • [36] Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease
    A. Lianne Messchendorp
    Edwin M. Spithoven
    Niek F. Casteleijn
    Wendy A. Dam
    Jacob van den Born
    Wouter F. Tonnis
    Carlo A. J. M. Gaillard
    Esther Meijer
    BMC Nephrology, 19 (1)
  • [37] Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease
    Messchendorp, A. Lianne
    Spithoven, Edwin M.
    Casteleijn, Niek F.
    Dam, Wendy A.
    van den Born, Jacob
    Tonnis, Wouter F.
    Gaillard, Carlo A. J. M.
    Meijer, Esther
    Drenth, Joost
    de Fijter, Johan W.
    Gansevoort, Ron T.
    Peters, Dorien J. M.
    Wetzels, Jack F. M.
    Zietse, Robert
    BMC NEPHROLOGY, 2018, 19
  • [38] Clinical Trials in Pediatric Autosomal Dominant Polycystic Kidney Disease
    Cadnapaphornchai, Melissa A.
    FRONTIERS IN PEDIATRICS, 2017, 5
  • [39] Is Autosomal Dominant Polycystic Kidney Disease Becoming a Pediatric Disorder?
    De Rechter, Stephanie
    Breysem, Luc
    Mekahli, Djalila
    FRONTIERS IN PEDIATRICS, 2017, 5
  • [40] Weight loss and cystic disease progression in autosomal dominant polycystic kidney disease
    Hopp, Katharina
    Catenacci, Victoria A.
    Dwivedi, Nidhi
    Kline, Timothy L.
    Wang, Wei
    You, Zhiying
    Nguyen, Dustin T.
    Bing, Kristen
    Poudyal, Bhavya
    Johnson, Ginger C.
    Jackman, Matthew R.
    Miller, Marsha
    Steele, Cortney N.
    Serkova, Natalie J.
    MacLean, Paul S.
    Nemenoff, Raphael A.
    Gitomer, Berenice
    Chonchol, Michel
    Nowak, Kristen L.
    ISCIENCE, 2022, 25 (01)
12345